Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria

Objective: We described the magnitude, type, and factors associated with first-line antiretroviral therapy (ART) modification in HIV-1-infected adults on ART in Jos, Nigeria. Method: Data on 6309 patients initiated on first-line ART between January 2004 and December 2006 were analyzed retrospectivel...

Full description

Bibliographic Details
Main Authors: Isaac Okoh Abah BPharm, MSc, Kristin M. Darin PharmD, Augustine Odo Ebonyi MBBS, MSc, Placcid Ugoagwu BSc, Victor Bazim Ojeh BPharm, Naima Nasir BPharm, Kakjing D. Falang BPharm MSc, Oluremi Olaitan BPharm, Msc, Oche Agbaji MBBS, John Idoko MBBS, Phyllis Kanki DVM, SD
Format: Article
Language:English
Published: SAGE Publishing 2015-07-01
Series:Journal of the International Association of Providers of AIDS Care
Online Access:https://doi.org/10.1177/2325957414565508
id doaj-b9e602390faa42a985a976030a53bcf2
record_format Article
spelling doaj-b9e602390faa42a985a976030a53bcf22020-11-25T03:46:05ZengSAGE PublishingJournal of the International Association of Providers of AIDS Care2325-95742325-95822015-07-011410.1177/2325957414565508Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in NigeriaIsaac Okoh Abah BPharm, MSc0Kristin M. Darin PharmD1Augustine Odo Ebonyi MBBS, MSc2Placcid Ugoagwu BSc3Victor Bazim Ojeh BPharm4Naima Nasir BPharm5Kakjing D. Falang BPharm MSc6Oluremi Olaitan BPharm, Msc7Oche Agbaji MBBS8John Idoko MBBS9Phyllis Kanki DVM, SD10 Jos University Teaching Hospital, Jos, Nigeria Feinberg School of Medicine, Northwestern University, Chicago, IL, USA University of Jos/Jos University Teaching Hospital, Jos, Nigeria Jos University Teaching Hospital, Jos, Nigeria Jos University Teaching Hospital, Jos, Nigeria Jos University Teaching Hospital, Jos, Nigeria University of Jos, Jos, Nigeria AIDS Prevention Initiative in Nigeria, Ltd./Gte, Lagos, Nigeria University of Jos/Jos University Teaching Hospital, Jos, Nigeria National Agency for the Control of AIDS (NACA), Abuja, Nigeria Harvard School of Public Health, Boston, MA, USAObjective: We described the magnitude, type, and factors associated with first-line antiretroviral therapy (ART) modification in HIV-1-infected adults on ART in Jos, Nigeria. Method: Data on 6309 patients initiated on first-line ART between January 2004 and December 2006 were analyzed retrospectively. Factors predictive of modification to initial ART were assessed by chi-square and multivariable logistic regression analysis. Results: Overall, 5212 (83%) included patients incurred a modification (73.3% drug substitution and 9.7% drug switch) to their initial first-line ARV regimen during a median (interquartile range) follow-up period of 7 (3-8) years. Drug substitutions of zidovudine (ZDV) were less likely than of tenofovir (TDF; adjusted odd ratio [AOR] 0.6; 95% confidence interval [CI]: 0.51-0.71), and Drug substitutions of efavirenz (EFV) were more likely than of nevirapine (NVP)-containing (AOR 1.82; 95% CI: 1.42-2.33) regimens. Predictors of switch to second-line regimen include older age (AOR 2.05; 95% CI: 1.68-2.51), CD4 count ≤100 cells/mm 3 (AOR 1.89; 95% CI: 1.49-2.37), EFV compared to NVP (AOR 1.38; 95% CI: 1.02-1.88), and drug toxicity (AOR 1.90; 95% CI: 1.48-2.43). Conclusion: Modification to initial ART was common in this study. Further evaluation of the contribution of guideline changes on regimen modification and treatment outcomes is recommended.https://doi.org/10.1177/2325957414565508
collection DOAJ
language English
format Article
sources DOAJ
author Isaac Okoh Abah BPharm, MSc
Kristin M. Darin PharmD
Augustine Odo Ebonyi MBBS, MSc
Placcid Ugoagwu BSc
Victor Bazim Ojeh BPharm
Naima Nasir BPharm
Kakjing D. Falang BPharm MSc
Oluremi Olaitan BPharm, Msc
Oche Agbaji MBBS
John Idoko MBBS
Phyllis Kanki DVM, SD
spellingShingle Isaac Okoh Abah BPharm, MSc
Kristin M. Darin PharmD
Augustine Odo Ebonyi MBBS, MSc
Placcid Ugoagwu BSc
Victor Bazim Ojeh BPharm
Naima Nasir BPharm
Kakjing D. Falang BPharm MSc
Oluremi Olaitan BPharm, Msc
Oche Agbaji MBBS
John Idoko MBBS
Phyllis Kanki DVM, SD
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
Journal of the International Association of Providers of AIDS Care
author_facet Isaac Okoh Abah BPharm, MSc
Kristin M. Darin PharmD
Augustine Odo Ebonyi MBBS, MSc
Placcid Ugoagwu BSc
Victor Bazim Ojeh BPharm
Naima Nasir BPharm
Kakjing D. Falang BPharm MSc
Oluremi Olaitan BPharm, Msc
Oche Agbaji MBBS
John Idoko MBBS
Phyllis Kanki DVM, SD
author_sort Isaac Okoh Abah BPharm, MSc
title Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
title_short Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
title_full Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
title_fullStr Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
title_full_unstemmed Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
title_sort patterns and predictors of first-line antiretroviral therapy modification in hiv-1-infected adults in a large urban outpatient cohort in nigeria
publisher SAGE Publishing
series Journal of the International Association of Providers of AIDS Care
issn 2325-9574
2325-9582
publishDate 2015-07-01
description Objective: We described the magnitude, type, and factors associated with first-line antiretroviral therapy (ART) modification in HIV-1-infected adults on ART in Jos, Nigeria. Method: Data on 6309 patients initiated on first-line ART between January 2004 and December 2006 were analyzed retrospectively. Factors predictive of modification to initial ART were assessed by chi-square and multivariable logistic regression analysis. Results: Overall, 5212 (83%) included patients incurred a modification (73.3% drug substitution and 9.7% drug switch) to their initial first-line ARV regimen during a median (interquartile range) follow-up period of 7 (3-8) years. Drug substitutions of zidovudine (ZDV) were less likely than of tenofovir (TDF; adjusted odd ratio [AOR] 0.6; 95% confidence interval [CI]: 0.51-0.71), and Drug substitutions of efavirenz (EFV) were more likely than of nevirapine (NVP)-containing (AOR 1.82; 95% CI: 1.42-2.33) regimens. Predictors of switch to second-line regimen include older age (AOR 2.05; 95% CI: 1.68-2.51), CD4 count ≤100 cells/mm 3 (AOR 1.89; 95% CI: 1.49-2.37), EFV compared to NVP (AOR 1.38; 95% CI: 1.02-1.88), and drug toxicity (AOR 1.90; 95% CI: 1.48-2.43). Conclusion: Modification to initial ART was common in this study. Further evaluation of the contribution of guideline changes on regimen modification and treatment outcomes is recommended.
url https://doi.org/10.1177/2325957414565508
work_keys_str_mv AT isaacokohabahbpharmmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT kristinmdarinpharmd patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT augustineodoebonyimbbsmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT placcidugoagwubsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT victorbazimojehbpharm patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT naimanasirbpharm patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT kakjingdfalangbpharmmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT oluremiolaitanbpharmmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT ocheagbajimbbs patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT johnidokombbs patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
AT phylliskankidvmsd patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria
_version_ 1724507990472523776